These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 37428619)
1. The Role of Long-Acting Antimuscarinic Agents in the Treatment of Asthma. Arslan B; Çetin GP; Yilmaz İ J Aerosol Med Pulm Drug Deliv; 2023 Aug; 36(4):189-209. PubMed ID: 37428619 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β Ferguson GT; Darken P; Ballal S; Siddiqui MK; Singh B; Attri S; Holmgren U; de Nigris E Adv Ther; 2020 Jun; 37(6):2956-2975. PubMed ID: 32335859 [TBL] [Abstract][Full Text] [Related]
3. Muscarinic antagonists in early stage clinical development for the treatment of asthma. Albertson TE; Chenoweth JA; Adams JY; Sutter ME Expert Opin Investig Drugs; 2017 Jan; 26(1):35-49. PubMed ID: 27927039 [TBL] [Abstract][Full Text] [Related]
4. Budesonide/Glycopyrronium/Formoterol: A Review in COPD. Heo YA Drugs; 2021 Aug; 81(12):1411-1422. PubMed ID: 34342835 [TBL] [Abstract][Full Text] [Related]
6. Current long-acting muscarinic antagonists for the treatment of asthma. Ora J; Calzetta L; Ritondo BL; Matera MG; Rogliani P Expert Opin Pharmacother; 2021 Dec; 22(17):2343-2357. PubMed ID: 34219573 [TBL] [Abstract][Full Text] [Related]
7. Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis. Ismaila AS; Haeussler K; Czira A; Tongbram V; Malmenäs M; Agarwal J; Nassim M; Živković-Gojović M; Shen Y; Dong X; Duarte M; Compton C; Vogelmeier CF; Halpin DMG Adv Ther; 2022 Nov; 39(11):4961-5010. PubMed ID: 35857184 [TBL] [Abstract][Full Text] [Related]
8. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma. Kew KM; Evans DJ; Allison DE; Boyter AC Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011438. PubMed ID: 26031392 [TBL] [Abstract][Full Text] [Related]
9. Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study. Hsieh MJ; Chen NH; Cheng SL; Tao CW; Wei YF; Wu YK; Chan MC; Liu SF; Hsu WH; Yang TM; Lin MS; Liu CL; Kuo PH; Tsai YH Int J Chron Obstruct Pulmon Dis; 2022; 17():967-976. PubMed ID: 35510163 [TBL] [Abstract][Full Text] [Related]
10. Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators. Halpin DM; Kaplan AG; Russell RK Respir Med; 2017 Jul; 128():28-41. PubMed ID: 28610667 [TBL] [Abstract][Full Text] [Related]
11. Understanding the role of long-acting muscarinic antagonists in asthma treatment. Muiser S; Gosens R; van den Berge M; Kerstjens HAM Ann Allergy Asthma Immunol; 2022 Apr; 128(4):352-360. PubMed ID: 35074516 [TBL] [Abstract][Full Text] [Related]
12. Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. Kew KM; Dias S; Cates CJ Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD010844. PubMed ID: 24671923 [TBL] [Abstract][Full Text] [Related]
13. New perspectives on the role of muscarinic antagonists in asthma therapy. Matera MG; Belardo C; Rinaldi M; Rinaldi B; Cazzola M Expert Rev Respir Med; 2020 Aug; 14(8):817-824. PubMed ID: 32316778 [TBL] [Abstract][Full Text] [Related]
14. Role of Long-Acting Muscarinic Antagonist/Long-Acting β Petite SE Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560 [TBL] [Abstract][Full Text] [Related]
15. Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β Requena G; Banks V; Czira A; Wood R; Tritton T; Wild R; Compton C; Duarte M; Ismaila AS Int J Chron Obstruct Pulmon Dis; 2022; 17():1781-1795. PubMed ID: 35983168 [TBL] [Abstract][Full Text] [Related]
16. Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives. Rhee CK; Yoshisue H; Lad R Adv Ther; 2019 Mar; 36(3):495-519. PubMed ID: 30742242 [TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Long-Acting Beta Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405 [TBL] [Abstract][Full Text] [Related]